<SEC-DOCUMENT>0001193125-25-004427.txt : 20250110
<SEC-HEADER>0001193125-25-004427.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110160112
ACCESSION NUMBER:		0001193125-25-004427
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250110
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Olema Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001750284
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				300409740
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39712
		FILM NUMBER:		25522812

	BUSINESS ADDRESS:	
		STREET 1:		780 BRANNAN STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		(415) 651-3316

	MAIL ADDRESS:	
		STREET 1:		780 BRANNAN STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d915597d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:olma="http://olema.com/20250110" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-255">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-01-10_to_2025-01-10">0001750284</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="olma-20250110.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-01-10_to_2025-01-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001750284</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-10</xbrli:startDate> <xbrli:endDate>2025-01-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-266">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt:datemonthdayyearen" id="ixv-267">January 10, 2025</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-268">Olema Pharmaceuticals, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-269">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-270">001-39712</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-271">30-0409740</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:49%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-272">780 Brannan Street</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-273">San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-274">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-275">94103</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-276">415</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-277">651-3316</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-278">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-279">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-280">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-281">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><br/>Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-282">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-283">OLMA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:exchnameen" id="ixv-284">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-285">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;3.02 Unregistered Sales of Equity Securities. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;10, 2025, the Company entered into exchange agreements with Bain Capital Life Sciences Opportunities IV, L.P. (&#8220;Bain&#8221;), entities affiliated with Paradigm BioCapital International Fund Ltd. (&#8220;Paradigm&#8221;) and entities affiliated with BVF Partners L.P. (&#8220;BVF&#8221;) (each, a &#8220;Holder&#8221; and collectively the &#8220;Holders&#8221;), pursuant to which (i)&#160;Bain agreed to exchange 3,500,000 shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), for one or more <span style="white-space:nowrap">pre-funded</span> warrants to purchase up to 3,500,000 shares of Common Stock, (ii)&#160;Paradigm agreed to exchange 2,150,000 shares of Common Stock for one or more <span style="white-space:nowrap">pre-funded</span> warrants to purchase up to 2,150,000 shares of Common Stock and (iii)&#160;BVF agreed to exchange 420,000 shares of Common Stock for one or more <span style="white-space:nowrap">pre-funded</span> warrants to purchase up to 420,000 shares of Common Stock (each of such <span style="white-space:nowrap">pre-funded</span> warrants, an &#8220;Exchange Warrant&#8221; and collectively, the &#8220;Exchange Warrants,&#8221; and such exchanges of Common Stock for Exchange Warrants collectively, the &#8220;Exchange&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Exchange Warrant will have an initial exercise price of $0.0001 per share of Common Stock, subject to certain adjustments. The Exchange Warrants will be exercisable immediately and may be exercised at any time until all of the Exchange Warrants are exercised in full. A Holder (together with its affiliates and other attribution parties) may not exercise any portion of an Exchange Warrant to the extent that immediately prior to or after giving effect to such exercise the Holder would own more than 9.99% of the Company&#8217;s outstanding Common Stock immediately after exercise, which percentage may be changed at the Holder&#8217;s election to a lower or higher percentage not in excess of 19.99% upon 61 days&#8217; notice to the Company subject to the terms of the Exchange Warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exchange Warrants will be issued without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemption from registration contained in Section&#160;3(a)(9) of the Securities Act. The Exchange is expected to close on January&#160;13, 2025. Following the closing of the Exchange on such date, the number of outstanding shares of Common Stock is estimated to be 68,333,065. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Exchange Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of the form of Exchange Warrant, which is filed as Exhibit 4.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 Financial Statements and Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit&#160;No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d915597dex41.htm">Form of Exchange Warrant.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Statements in this Current Report on Form <span style="white-space:nowrap">8-K</span> that are not strictly historical in nature are forward-looking statements. These statements include but are not limited to statements regarding the completion of the Exchange and the estimated number of outstanding shares of Common Stock following the Exchange. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any forward-looking statement due to various factors, including such risks and uncertainties. For a discussion of these and other factors, please refer to the section titled &#8220;Risk Factors&#8221; in the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarter ended September&#160;30, 2024. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by law. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="font-size:1pt">
<td style="height:12pt" colspan="3"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: January&#160;10, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Shane Kovacs</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:10pt; font-family:Times New Roman">Shane Kovacs</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:10pt; font-family:Times New Roman">Chief Operating and Financial Officer</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d915597dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR ANY OTHER
APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER APPLICABLE SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE
REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR NOT SUBJECT TO,
SUCH REGISTRATION, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PRE-FUNDED</FONT>
COMMON STOCK PURCHASE WARRANT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OLEMA PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrant Shares: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of Issuance: &#8195;&#8195;&#8195;&#8195;,
2025 (such date, the &#147;<U>Issue Date</U>&#148;) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrant No.: <FONT STYLE="white-space:nowrap">PF-[&#8195;]</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS COMMON STOCK PURCHASE WARRANT (the &#147;<U>Warrant</U>&#148;) certifies that, for value received, the registered holder hereof or its permitted assigns
(the &#147;<U>Holder</U>&#148;) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth herein, at any time on or after the Issue Date, to subscribe for and purchase from <B>Olema Pharmaceuticals,
Inc.</B>, a Delaware corporation (the &#147;<U>Company</U>&#148;), up to &#8195;&#8195;&#8195;&#8195;shares (the &#147;<U>Warrant Shares</U>&#148;) of the Company&#146;s common stock, par value $0.0001 per share (&#147;<U>Common Stock</U>&#148;).
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b). This Warrant is one of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Common Stock Purchase Warrants
issued in connection with the transactions contemplated by that certain Exchange Agreement, dated [&#149;], 2025, by and among the Company and the Stockholder identified therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;1</U>. <U>Definitions</U>. For purposes of this Warrant, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) &#147;<U>Affiliate</U>&#148; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &#147;<U>1933 Act</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) &#147;<U>Attribution Parties</U>&#148; means, collectively, the following Persons and entities: (i)&nbsp;any investment vehicle, including, any funds,
feeder funds or managed accounts, currently, or from time to time after the Issue Date, directly or indirectly managed or advised by the Holder&#146;s investment manager, (ii)&nbsp;any direct or indirect Affiliates of the Holder or any of the
foregoing, (iii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv)&nbsp;any other Persons whose beneficial ownership of Common Stock would or could be aggregated with the
Holder&#146;s and the other Attribution Parties for purposes of Section&nbsp;13(d) or Section&nbsp;16 of the Securities Exchange Act of 1934, as amended (the &#147;<U>1934 Act</U>&#148;). For clarity, the purpose of the foregoing is to subject
collectively the Holder and all other Attribution Parties to the Maximum Percentage (as defined in Section&nbsp;2(e)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c) &#147;<U>Bloomberg</U>&#148;
means Bloomberg Financial Markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">d) &#147;<U>Business Day</U>&#148; means any day except any Saturday, any Sunday, any day that is a federal legal
holiday in the United States or any day on which the New York Stock Exchange is authorized or required by law or other governmental action to close. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">e)
&#147;<U>Group</U>&#148; means a &#147;group&#148; as that term is used in Section&nbsp;13(d) of the 1934 Act and as defined in Rule <FONT STYLE="white-space:nowrap">13d-5</FONT> thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">f) &#147;<U>Person</U>&#148; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated
organization, any other entity and a government or any department or agency thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">g) &#147;<U>Standard Settlement Period</U>&#148; means the standard settlement period, expressed in a number
of Trading Days, for the Trading Market with respect to the Common Stock that is in effect on the date of delivery of an applicable Notice of Exercise, which as of the Issue Date was &#147;T+1.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">h) &#147;<U>Trading Day</U>&#148; means any day on which the Common Stock is traded on the Trading Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">i) &#147;<U>Trading Market</U>&#148; means the principal securities exchange or securities market, including an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, on which the Common Stock is then traded in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">j) &#147;<U>Weighted
Average Price</U>&#148; means, for any security as of any date, the dollar volume-weighted average price for such security on the Trading Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York
City time, as reported by Bloomberg through its &#147;Volume at Price&#148; function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by
Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as
reported in the &#147;pink sheets&#148; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices). If the Weighted Average Price cannot be calculated for such security on such date on
any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then such dispute shall be resolved pursuant to Section&nbsp;5(n) with the term &#147;Weighted Average Price&#148; being substituted for the term &#147;Exercise Price.&#148; All such determinations shall be appropriately adjusted for
any stock dividend, stock split, stock combination or other similar transaction during such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;2</U>. <U>Exercise</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) <U>Exercise of Warrant</U>. Subject to the terms and conditions hereof, the purchase rights represented by this Warrant may be exercised, in whole or
in part, at any time or times on or after the Issue Date by delivery (whether via facsimile or otherwise) to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address
of the Holder appearing on the books of the Company) of a duly executed copy of the Notice of Exercise form annexed hereto (the &#147;<U>Notice of Exercise</U>&#148;) and by payment to the Company of an amount equal to the aggregate Exercise Price
of the Warrant Shares thereby purchased by wire transfer (or by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined below)). No <FONT STYLE="white-space:nowrap">ink-original</FONT> Notice of
Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. The Holder shall not be required to physically surrender this Warrant to the Company until the
Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case the Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days after the date
the Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. <B>The Holder and
any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof. </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) <U>Exercise Price</U>. The exercise price per share of Common
Stock under this Warrant shall be $0.0001, subject to adjustment as provided herein (the &#147;<U>Exercise Price</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c) <U>Mechanics of
Exercise</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">i. <U>Delivery of Warrant Shares Upon Exercise</U>. Certificates for shares purchased hereunder shall be transmitted to the Holder by
crediting the account of the Holder&#146;s prime broker with The Depository Trust Company (&#147;<U>DTC</U>&#148;) through its Deposit/Withdrawal at Custodian (&#147;<U>DWAC</U>&#148;) system if the Company is then a participant in such system and
either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrant Shares by the Holder or (B)&nbsp;the Warrant Shares are eligible for resale by the Holder without volume or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> limitations pursuant to Rule 144 (assuming cashless exercise of the Warrant), and otherwise by physical delivery to the address specified by the Holder in
the Notice of Exercise no later than the number of Trading Days comprising the Standard Settlement Period after the receipt by the Company of the Notice of Exercise (provided that payment of the Exercise Price (or notification of Cashless Exercise,
if applicable) has then been received by the Company) (such date, the &#147;<U>Warrant Share Delivery Date</U>&#148;). This Warrant shall be deemed to have been exercised upon proper delivery of the Notice of Exercise and payment of the Exercise
Price (or notification of Cashless Exercise). The Warrant Shares shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all
purposes, as of the date the Warrant has been exercised. The Company shall use commercially reasonable efforts to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ii. <U>Delivery of New Warrant Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon
surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called
for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">iii. <U>Compensation for <FONT
STYLE="white-space:nowrap">Buy-In</FONT> on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant
Shares in accordance with the provisions of Section&nbsp;2(c)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect or incomplete information provided by the Holder to the Company),
and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#146;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder
of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#147;<U><FONT STYLE="white-space:nowrap">Buy-In</FONT></U>&#148;), then the Company shall promptly, and in any event within two (2)&nbsp;Business Days, either
(A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&#146;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, or
(B)&nbsp;at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the
number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a <FONT
STYLE="white-space:nowrap">Buy-In</FONT> with respect to an attempted exercise of this Warrant with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. In connection with the foregoing, the Holder shall provide the Company written notice within three (3)&nbsp;Business Days after the occurrence of a <FONT STYLE="white-space:nowrap">Buy-In,</FONT>
indicating the amounts payable to the Holder in respect of the <FONT STYLE="white-space:nowrap">Buy-In</FONT> and, upon request of the Company, evidence of the amount of such loss. Subject to Section&nbsp;5(i), nothing herein shall limit a
Holder&#146;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#146;s failure to timely deliver
Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>iv. No Fractional Shares or Scrip</U>. No fractional shares or
scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash
adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round (up or down) to the nearest whole share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">v. <U>Charges, Taxes and Expenses</U>. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the
Holder; <U>provided</U>, <U>however</U>, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached
hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">vi. <U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which
prevents the timely exercise of this Warrant pursuant to the terms hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">d) <U>Cashless Exercise</U>. Notwithstanding anything contained herein to the
contrary, the Holder may exercise this Warrant, whether in whole or in part, and in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Exercise Price, by effecting a cashless
exercise of this Warrant pursuant to which the Holder shall receive upon such cashless exercise the &#147;Net Number&#148; of Warrant Shares determined according to the following formula (a &#147;<U>Cashless Exercise</U>&#148;): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:4%">


<IMG SRC="g915597g14b44.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing formula: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">A&nbsp;=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock with respect to which this Warrant is then being exercised.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">B&nbsp;=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Weighted Average Price of the shares of Common Stock on the date immediately preceding the date of the Notice of Exercise.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">C&nbsp;=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Warrant Shares are issued in such a Cashless Exercise, the Company acknowledges and agrees that in accordance with
Section&nbsp;3(a)(9) of the 1933 Act, the Warrant Shares shall take on the characteristics of the Warrant being exercised, and the holding period of the Warrant being exercised may be tacked on to the holding period of the Warrant Shares. The
Company agrees not to take any position contrary to this Section&nbsp;2(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">e) <U>Holder&#146;s Exercise Limitations</U>. Notwithstanding anything to the
contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such
exercise shall be null and void and treated as if never made, to the extent that immediately prior to or after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of
9.99% (the &#147;<U>Maximum Percentage</U>&#148;) of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock
beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this
Warrant with respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A)&nbsp;exercise of the remaining, unexercised portion of this Warrant beneficially
owned by the Holder or any of the other Attribution Parties and (B)&nbsp;exercise or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible
preferred stock or warrants, including the other Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section&nbsp;2(e). For
purposes of this Section&nbsp;2(e), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d) of the 1934 Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section&nbsp;13(d) of the 1934 Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section&nbsp;13(d) of the 1934 Act and the rules and regulations promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding shares of
Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&#146;s most recent Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or other public filing with the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;), as the case may be, (y)&nbsp;a more recent public announcement by the Company or (z)&nbsp;any other written notice by the Company
setting forth the number of shares of Common Stock outstanding (the &#147;<U>Reported Outstanding Share Number</U>&#148;). If the Company receives a Notice of Exercise from the Holder at a time when the actual number of outstanding shares of Common
Stock is less than the Reported Outstanding Share Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the
Holder&#146;s beneficial ownership, as determined pursuant to this Section&nbsp;2(e), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (the
number of shares by which such purchase is reduced, the &#147;<U>Reduction Shares</U>&#148;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For
any reason at any time, upon the written request of the Holder, the Company shall within five (5)&nbsp;Business Days confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of
which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the
aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d) of the 1934 Act), the number of shares so issued by which the Holder&#146;s and the other Attribution
Parties&#146; aggregate beneficial ownership exceeds the Maximum Percentage (the &#147;<U>Excess Shares</U>&#148;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the
Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written
notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage (not in excess of 19.99% of the issued and outstanding shares of Common Stock immediately after giving effect to the issuance
of the shares of Common Stock issuable upon exercise of this Warrant) as specified in such notice; <U>provided</U> that (i)&nbsp;any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is
delivered to the Company and (ii)&nbsp;any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the
shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section&nbsp;13(d) or Rule <FONT
STYLE="white-space:nowrap">16a-1(a)(1)</FONT> of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e) to the extent necessary to correct this paragraph or any
portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section&nbsp;2(e) or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;3</U>. <U>Certain Adjustments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) <U>Subdivision or Combination </U><U>of Common Stock</U>. During such time as this Warrant is outstanding, if the Company subdivides (by any stock split,
stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the
number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a
smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section&nbsp;3(a) shall
become effective at the close of business on the date the subdivision or combination becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) <U>Subsequent Rights Offerings</U>. In
addition to any adjustments pursuant to Section&nbsp;3(a) above, if during such time as this Warrant is outstanding the Company grants, issues or sells any rights to purchase stock, warrants, securities or other property, in each case pro rata to
the record holders of any class of shares of Common Stock (the &#147;<U>Purchase Rights</U>&#148;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, Section&nbsp;2(e) hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of
which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights <U>(provided</U>, <U>however</U>, to the extent that the Holder&#146;s right to participate in any such Purchase Right would
result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the
Maximum Percentage). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c) <U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or
options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#147;<U>Distribution</U>&#148;), at any time after the issuance of this Warrant, then, in each such case, the
Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, Section&nbsp;2(e) hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record
holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder&#146;s right to participate in any such Distribution would result in the Holder and the
other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to
such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">d) <U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one
or more related transactions effects any merger or consolidation with or into another Person, in which the Company is not the surviving entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own,
directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii)&nbsp;the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets in one or a series of related transactions (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual property), (iii) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of
the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, <FONT STYLE="white-space:nowrap">spin-off</FONT> or scheme of arrangement) with another
Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other
Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#147;<U>Fundamental Transaction</U>&#148;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive,
for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (together, the &#147;<U>Alternate Consideration</U>&#148;), if any,
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)
on the exercise of this Warrant). For purposes of any such exercise, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this
Warrant following such Fundamental Transaction. Any such payment of such amount of such Alternate Consideration shall be made in the same form of consideration (whether securities, cash or property) as is given to the holders of Common Stock in such
Fundamental Transaction, and if multiple forms of consideration are given, the consideration shall be paid to the Holder in the same proportion as such consideration is paid to the holders of Common Stock. The terms of any agreement pursuant to
which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section&nbsp;3(d) and insuring that this Warrant (or any such replacement security) will be
similarly adjusted upon any subsequent Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#147;<U>Successor Entity</U>&#148;) to assume in writing all of
the obligations of the Company under this Warrant in accordance with the provisions of this Section&nbsp;3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of
the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for the Company (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#147;Company&#148; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Notwithstanding the foregoing, and without limiting
Section&nbsp;2(e) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section&nbsp;3(d) to permit a Fundamental Transaction without the assumption of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">e) <U>Calculations</U>. All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest whole share, as the case may be. For
purposes of this Section&nbsp;3, any calculation of the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall not include treasury shares, if any. In any case in which this Section&nbsp;3 shall require that an
adjustment in the Exercise Price be made effective as of a record date for a specified event, if Holder exercises this Warrant after such record date, the Company may elect to defer, until the occurrence of such event, the issuance of the shares of
Common Stock and other capital stock of the Company in excess of the shares of Common Stock and other capital stock of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment;
<U>provided</U>, <U>however</U>, that in such case the Company shall deliver to the Holder a due bill or other appropriate instrument evidencing the Holder&#146;s right to receive such additional shares and/or other capital securities upon the
occurrence of the event requiring such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">f) <U>Par Value</U>. Notwithstanding anything to the contrary in this Warrant, in no event shall the
Exercise Price be reduced below the par value of the Company&#146;s Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;4</U>. <U>Transfer of Warrant</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) <U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in whole or in
part, upon surrender of this Warrant at the principal office of the Company (or other designated agent), together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or
attorney and funds sufficient to pay any transfer taxes payable upon the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as
applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The
Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) <U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company (or other
designated agent), together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section&nbsp;4(a), as to any transfer which
may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
exchanges shall be dated the Issue Date set forth on the first page of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c) <U>Warrant Register</U>. The Company shall initially serve as warrant agent under this Warrant. The Company shall register ownership of this Warrant, upon
records to be maintained by the Company for that purpose (the &#147;<U>Warrant Register</U>&#148;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned
hereunder) from time to time. Upon thirty (30)&nbsp;days&#146; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any
consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor
warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#146;s last
address as shown on the Warrant Register. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent
actual notice to the contrary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;5</U>. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) <U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section&nbsp;2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) <U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company
covenants that upon receipt by the Company of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction,
of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c) <U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">d) <U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant (without regard to any limitations on exercise contained herein). The Company further covenants that
its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the
Trading Market. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such
Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, in each case to avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out
of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will
(i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public
regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">e) <U>Governing
Law</U>. This Warrant shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to the conflicts of law principles thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">f) <U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate as a
waiver of such right or otherwise prejudice the Holder&#146;s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#146; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">g)
<U>Notices</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">i. <U>Notice Procedures</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of: (a)&nbsp;the date of transmission, if such notice or communication is delivered via email or facsimile at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via email or facsimile on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)&nbsp;the second
(2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or by International Federal Express, (d)&nbsp;the third (3rd) Trading Day following the date of mailing if sent by first-class
registered or certified mail domestic, or (e)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Olema
Pharmaceuticals, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">780 Brannan Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">San Francisco, California 94103 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Chief Executive Officer </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3 Embarcadero Center, 20<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: Kristin VanderPas </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If
to the Holder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the address, email address or facsimile number set forth in the Warrant Register, or as otherwise provided by the Holder
to the Company in accordance with this Section&nbsp;5(g)(i). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ii. <U>Adjustment to Exercise Price</U>. Whenever the Exercise Price or number of Warrant Shares is adjusted
pursuant to any provision of Section&nbsp;3, the Company shall promptly provide the Holder a notice setting forth the Exercise Price and number of Warrant Shares after such adjustment and setting forth a brief statement of the facts requiring such
adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">iii. <U>Notice to Allow Exercise by the Holder</U>. After the Issue Date if (A)&nbsp;the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the Company shall authorize the granting to all holders of the Common Stock
rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any
consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual
property), or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of
the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register, at least ten (10)&nbsp;calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of
record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; <U>provided</U> that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the
extent that any notice provided hereunder constitutes, or contains, material, <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any of its subsidiaries, the Company shall promptly file such notice with the SEC
pursuant to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">h) <U>Limitation of Liability</U>. No provision hereof, in the absence
of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common
Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">i) <U>Remedies</U>. The
Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. Notwithstanding
the foregoing or anything else herein to the contrary, if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof, the Company shall have no obligation to pay to
the Holder any cash or other consideration or otherwise &#147;net cash settle&#148; this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">j) <U>Successors and Assigns</U>. Subject to applicable
securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The
provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">k) <U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">l) <U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the
remaining provisions of this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">m) <U>Confidentiality</U>. The Holder agrees to keep confidential any proprietary information relating to
the Company delivered by the Company hereunder; provided that nothing herein shall prevent the Holder from disclosing such information: (i)&nbsp;to any holder of Warrants or Warrant Shares, (ii)&nbsp;to any Affiliate of any holder of Warrants or
Warrant Shares or any actual or potential transferee of the rights or obligations hereunder that agrees to be bound by this Section&nbsp;5(m), (iii) upon order, subpoena, or other process of any court or administrative agency or otherwise required
by law, (iv)&nbsp;upon the request or demand of any regulatory agency or authority having jurisdiction over such party, (v)&nbsp;which has been publicly disclosed without breach of any obligation to the Company, (vi)&nbsp;which has been obtained
from any Person that is not a party hereto or an Affiliate of any such party without any breach of any obligation to the Company, (vii)&nbsp;in connection with the exercise of any remedy, or the resolution of any dispute hereunder, (viii)&nbsp;to
the legal counsel or certified public accountants for any holder of Warrants or Warrant Shares, or (ix)&nbsp;as otherwise expressly contemplated by this Warrant. Notwithstanding the foregoing, the Company shall not provide material, <FONT
STYLE="white-space:nowrap">non-public</FONT> information or confidential or proprietary information to the Holder without such Holder&#146;s written consent. If the Company does provide material, <FONT STYLE="white-space:nowrap">non-public</FONT>
information or confidential or proprietary information to the Holder without such Holder&#146;s written consent, the Company shall promptly file such information with the SEC pursuant to a Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> and the Holder shall not be subject to any duty of confidentiality contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">n) <U>Dispute
Resolution</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within two
(2)&nbsp;Business Days of receipt of the Notice of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant
Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2)&nbsp;Business Days submit via facsimile (i)&nbsp;the disputed determination of the
Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (ii)&nbsp;the disputed arithmetic calculation of the Warrant Shares to the Company&#146;s independent, outside accountant. The Company
shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10)&nbsp;Business Days from the time it
receives the disputed determinations or calculations. Such investment bank&#146;s or accountant&#146;s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. The expenses of the investment bank
and accountant will be borne by the Company unless the investment bank or accountant determines that the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares by the Holder was incorrect, in which case the expenses
of the investment bank and accountant will be borne by the Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">o) <U>Headings</U>. The headings used in this Warrant are for the convenience of
reference only and shall not, for any purpose, be deemed a part of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******************** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Pages Follow) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly
authorized as of the date first above indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>OLEMA PHARMACEUTICALS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TO: OLEMA PHARMACEUTICALS, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) The undersigned holder of
Warrant No. PF-<U>&#8195;</U><U>&#8195;</U><U>&#8195;</U><U>&#8195;</U> hereby elects to purchase &#8195;&#8195;&#8195;&#8195;Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Payment shall take the form of (check applicable
box): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744; Cash Exercise: lawful money of the United States; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744; Cashless Exercise: the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
Section&nbsp;2(d), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section&nbsp;2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) By its delivery of this Notice of Exercise, the undersigned represents and warrants to the Company that in giving effect
to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section&nbsp;13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned
under Section&nbsp;2(e) of the Warrant to which this notice relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Shares shall be delivered to the following DWAC Account Number or by
physical delivery of a certificate to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[SIGNATURE OF HOLDER] </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name&nbsp;of&nbsp;Investing<BR>Entity:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Signature&nbsp;of&nbsp;Authorized&nbsp;Signatory&nbsp;of&nbsp;Investing Entity:</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name&nbsp;of&nbsp;Authorized Signatory:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title&nbsp;of&nbsp;Authorized Signatory:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(To assign the foregoing warrant, execute </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">this form and supply required information. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Do not use this form to exercise the warrant.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, [&#8195;&#8195;&#8195;&#8195;] all of or [&#8195;&#8195;&#8195;&#8195;] shares of the foregoing Warrant and all rights evidenced thereby
are hereby assigned to </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#8195;whose</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">address&nbsp;is</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.60em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated: ,</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holder&#146;s<BR>Signature:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holder&#146;s<BR>Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without
alteration or enlargement or any change whatsoever. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>olma-20250110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/10/2025 8:38:56 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:olma="http://olema.com/20250110"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://olema.com/20250110"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="olma-20250110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="olma-20250110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>olma-20250110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/10/2025 8:38:56 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>olma-20250110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/10/2025 8:38:57 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="olma-20250110.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g915597g14b44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g915597g14b44.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H:7)A;FII
M8F5E($IE;F$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,W
M-P  DI(  @    ,W-P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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LW^['G=@[AC->ST4+27-_7?\ 0'K'E_KJOU"BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46369637501968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001750284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Olema Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">30-0409740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">780 Brannan Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-3316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OLMA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( "6 *EJCV^/B[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( "6 *EJ97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ )8 J
M6M54A>5.!   F1   !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( "6 *EJ?H!OPL0(  .(,   -
M      "  9$,  !X;"]S='EL97,N>&UL4$L! A0#%     @ )8 J6I>*NQS
M    $P(   L              ( !;0\  %]R96QS+RYR96QS4$L! A0#%
M  @ )8 J6APX9>H_ 0  / (   \              ( !5A   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( "6 *EHD'INBK0   /@!   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M "6 *EIED'F2&0$  ,\#   3              "  :<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  /$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d915597d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d915597d8k.htm">d915597d8k.htm</File>
    <File>olma-20250110.xsd</File>
    <File>olma-20250110_lab.xml</File>
    <File>olma-20250110_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d915597d8k.htm": {
   "nsprefix": "olma",
   "nsuri": "http://olema.com/20250110",
   "dts": {
    "inline": {
     "local": [
      "d915597d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "olma-20250110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "olma-20250110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "olma-20250110_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d915597d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d915597d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://olema.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-004427-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-004427-xbrl.zip
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M7//R_,OI-[[:1 82=^E)1Y+GO5K4FH5JZF$5K!$X*!=4N?0K^>P)<'S!D?'
ME2%?J+Q;5K=_3:^KX[OHB3+2FQ!')\EAQCM0>:8/6,UEIKDBX$J"-XM ;\FM
M%*-P@ YM@-EJJHC+^MPWQYE-CM"JD<7+$],[$Q6RBRP_.#*)PJ0WP '.!'@2
M&FLL&[K%Y5XAS=EL=F,CA;Z9C[P ((-G\7FW/]9SJKV"ZFMJWLFPSWI4RPQZ
MN1"N]D (][+TZ?0?D,T\2.120><+U9<!B+'63Q!C7^C (U),]P*"Q34>?%,!
MU^4;<X\8":1A>1,$/N( &IGC W[0(MD]5S .E ,/@H )H(Z#!XNQ,[ZSP*72
M5::ZXSX8]51V:1KU9"6Z2%*R;Z_$^*-=.S9UQKC:N+.S7!C9<$$6\:>,9]-C
MP&WP;+P1G2ATW&#JG>-!Z@1!_"=DXZ>Z_G.4K"889V,\QV-4XK8WT-'4SIIR
M[G8OE.^\WI48T,N0#?%P@V4? 4?+Y#<_$]YWJ<?T$9/VUPB,5<9>%\EJ@[&_
M E%-#5!T(!IFO1YG/RY]$M\_BU4MOH26U[H6&TZB^:$W.%#-Q%$F]%8RG>-1
M1O4_4M@ 6S3@(:CZ.>_#1N1P_7(&<AG@28#(-YM2Y_<\.2]>%7$C.BR7K2,<
MJ;_:1WMYHM^-@/UH'PO'%&V2!G!%T6&['9*/7"1P.HB:KRTY/)U%ODO.0W<Z
M=3(FF1X,E+L:PL??SQ!*Z#.IYE#\_2R=8A<#ACRA)&[[!5C.9-RL 6 R!"W8
M/?-,!7RFIYJN-6OS3,2QR_<,*S0Y-8UU>3TE>R5?LZP\*+GQL55B&&-FI4=J
M'..EJ[5>.MG-8)CU[:=HHJ''PSGP,00KL-YS""0K]#%%YR:NPXA*W&D4K@56
M#8N!_24*\''9BF9CC%V>4"65@264*>?MVD/SO/ RUH)'R8"5I P&85NRBFKY
M#=>P!KB6?/Q51?#Y#-!Y=%MBD4MW]#],XRI%RF<U:7Z0RF>':?02BBZGX<($
MZV$E^O"0E38WFK=MIMM(]GF,P61Y'GAN]PR)R=&X@@ED8R8=\+O K^*.3F\L
M*OR"?JFH]S<&9R !#L24VO*X?T<JU.:]2&ZRCE=*, V_QQ*0.GO,AT/FHD4%
MPX><&-))I@N(.@VUCQC"$@GZ@N 5PBSSSET* ]&=#@:\^I'G%<DI,:84;)>X
M-5&;-N \S!AUI3$0NI6&H>2]R'BO8.'!^N]IY-#;36F&F.%.%1]1 K(N$!U(
ME'K%\#2 ]637#%0'X8).\"_MP]Y$;OD].KRLWX\I' MG#!(GB]<R$I$'^(Y\
MH]DPMT_JQ7K]PRH3+Z)0^]$X_XR SW!!8Y' R\?;# @#NEG@WR4L<N(#?#3,
MX)2"TL$!D@460(DG1C G+'$ /@]\R\R&] 0V@?+%YVAMLX0H@,'[-G'!?8QG
MQ;XHHS%)$V\C(XSX,V _5"L%Y/5U\6%=X%@X--X$<"<-L33I5IX;BM,">4PF
MT*&)MK*;\FSWZ;8,=)8,1!U/7")KM%RR8:"A]:48SL+'\)<FF8J9" L#K-WZ
MWO*LQ9SZ0_C/QH$)%=%>>$)IZ+-^9,7XD45REA[CPYFQMSX*.,=.=%10+?!M
M"<;V^OI +7;,2OF*?0EQ4F!2:(P4,&+_,%\!DEK[M;<1$8R6;@7B[#+E2!YD
MSSTNRH\K8 K4'=B0]5LLS"IT=,U"IBT9K/)KA+<4XKOS:.S0E94,@@B(\-.W
MH26J@[92KV1ZIE(.=> Q!S^Q"@ !;"<: 4P=#7B/AZ1:M,U\T-B*I$2S%[]I
M Q;TZ,.C\4)X>F$1H,W@#O:$<?]!IAV^=,Q6+\)^>9;F+?1%%!/I(/HQ919M
MS]R+35ZR_/KQ\OI3^[K0NCP_/[WJMAO)EZW?@=O9,158_>&6XL]-:J8'*VJF
M=>O5:J8;USN)[G"26W*2?*-#%1M4P$CR@DOS\L]"SP/+M?6:5BR;1K N1/$)
M!<"%<L0L;>8. /P Y>9/4P,]6^6+97^)>B](6G+5 !I**ULPQ$ K>)(KO]IU
MPL4:T5(&@)5_KI@\<$;IF!+S\D^W;M=J]0.7C:MV<1#"9&<KMB207+JJX/HC
M,\*VJB_(B): 7\D5.NHZ<T9UO$L^T9 2?5]]EX';Y;JQ"\N-4]G1%HO@^XK!
M43%OR,+:3ZHG:XIV+[-?+]Z#T]\;F!?DCI:L$95NX5R(._3#,KMXYKS7*R9;
M,PAHPF['H=(A*(;)Z#V"K\^=$*(^F#P4$MF/L'P:1M #>_5CJG@Q552*E/;S
M%<O\@EZ:%[F,0."<@O#XD,=N=J8G.+LP:^KF&[=UF<>+#I0.5%)__5&>?G\F
MG$AF78*ZSG/X.B)G\<LR%,&7![M(92>F._?35V^;S+".;.)#BMI5]>^%AQF6
M#)J2JSO3&OEQNL0D[R%8BC %<Z\QT"4P%7GP%4-LE^,YTO2 /F"F(S2($W6R
M1OQM0BI,O4 0O))-Q(VT?W]/)1<1^.N@PD+B';STPJ2.I%8B>8:9"71&G$B_
M)R/FD&*9;$DZ*7 1DX/:.T^B"I5D O DB9O$J-< CYR9<4DJ+C8?\VF+?T?Z
M?5] @<>*O6T5_IW>0A,FEOYJ9B,F;.ZR($03)N/ UM0SJD7ROR+2,N%0G02:
MUCG!)W,P%85TG8NFU4/JDL1,*H!MPH@:3?,4&,?J2$;T3?B<)#=T#B"D=SK:
MR]Z(PU!:@%!B.D"2*- SF'0( ID!:Q)>F"R()0S!8M4U(\YYB/ZTTKL@CIX(
MXL&8/<;1(YT+PBQ-,)_3DOA&=VG",H^.'HIRLH9]=3$M&^?L9,N1X%Z]5R1?
MI2*Y]!7,G<\7IS>_7;>[KYX@R;X U9Q$T")G+/=FIUCRRXXPN!%H(6@X6GF]
MOYIW?L;)% 6K-^8?,R<]-J!>'X4<)])Z&7= O8VPU*FG UX-8"?]#W-_R'A_
M/L*?NT91PUA]\YA_Y9MN-IQFQ2GK+2%12Q,/CX_LD,.9N*&R(KJ8ZU;>O-N;
M1"$QU;/KTJ_3;2P_%O 2[]5I?IPTMCWOTXX7KSE4,VOSRD5+;TB/LGOK0I:2
M*I$NF#I&?A7WU%%+[Z6\D8QL=-?BD0SZ7N9\=#XPZP!4GB(ILU+PSO[_9^QO
M#3CKD\N 8>D.P@X,S:;U"/,:(CF7K$R3,/,^]G')_&=+^O]A:OX74$L#!!0
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MU>]V"-#NN_MXK<,!?+L_@#/ A\'^_LG9 =WR)P W$-#1TDM!^FFFWZ]"/IJ
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MO6AK#K]>9%:7#<@2O3,8]9VR?\RW-=DCXKZ=88_X:3(=)0\#B4#2\U&H2.3
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M !370$WPL16(4RKCP,/X%()[Q!#(59[E",Z>'U'P'PY55%@8)#IP-.(>S==
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MBO?5P&O=2 U=C.\MX:0-03QS3%G.V?4\3D+/:5_:9OAKULE"_&#H"*P7Z^I
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M_&S_YR>7KW9>O'CUT^7.\]'SYUN_SR^1$UW\_.3HY)<39BD/3#_UECUN&8D
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MBU27'Q3Y;)%R^\_*"3,G6H=Q=+-:5EZ8=9206D(M2FSD,\QU@=^(_XP/1I'
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MW:_XSNG,S/D+THQOW^3"!DKZ^7#?2POF&BI.E&0;N&_S7V-N&B^$)<B'O:%
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M$Y-:+H+,)4N2FIB,E4R7YY8YC?"+_"H9)2)VV8G1N#J+9.YP9)9USF!WZ*?
M:[-;OTC8H;PF08>+3HF4[V)GG 0VGY@XZ7XN'19L4?!#-)RPE4B_W7C,SO;W
M@,Q]Z'7&76;S;,IM8V)+LA>._#8ZU6>EYI2&JQ_7A 0Z/JN"O@%IRIX]QYV3
M;15H[L:^?6UM7E*^<(P;KN15L\X+[N3H&A\H/29)B6X3T[#2V=.N,P:5S9B:
MC"B==D#&D'+2Z/EG SUT38NOQG5JM6&BQDFN$II=>260U#X.I>K&F:L@.%W9
M22TUEX-J0+[(;-5:$'N=F<&7I"504C_RK-$\5UG<]YPWNFTKNY87!5<J3V;
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M_L/%)7QKO&<P1HG<(I3<.C3POA:RR(:#X4Z:#H=)VJ<9Y-X?%-QA!BE+!XR
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M98_SVMVN4MW]9<L7N-WI7_1FJQDT]/,W4$L#!!0    ( "6 *EH[#YA(7 8
M +Y#   5    ;VQM82TR,#(U,#$Q,%]L86(N>&ULS9QM;]LV$,??%^AWN'EO
M-J"RXZ0=6J-ID3E)$2Q/2-QMV# 4LL38Q"32(.7$_O8C]=#(,253X6G*B[:*
M=/>_^\N_4VE9SL?/JSB">R(DY>RP-^SO]8"P@(>4S0Y[2^GY,J"T!S+Q6>A'
MG)'#WIK(WN=/KU]]_,'SX/CT[!(\F"?)0HX&@X>'AWYX1YGDT3)1DK(?\'@
MGE?$CR=?X?>LW AN2$1\22#V94($_+JD43C:W]M_.QSN[_>'Y31!?*T'H9^0
M$0P'P[V!"GP'[T<'[T?O?H'K"SA)51A,:$S*J7RQ%G0V3^"GX&=(DXXY8R2*
MR!I.*?-90/T(;HN.W\ 9"_IP%$5PH].D:E,2<4_"?JX:4?;O2/\UU<W#ZU<
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M\P_&BD*058*\%-)G?"W:,'S(9^NEO.-<;>G?.Y'OHMEO7U![_@-02P,$%
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M4$L! A0#%     @ )8 J6IG(5SO12   O%P! !               ( !4!,
M &0Y,34U.3=D97@T,2YH=&U02P$"% ,4    "  E@"I:1A#MKSH#   W"P
M$0              @ %/7   ;VQM82TR,#(U,#$Q,"YX<V102P$"% ,4
M"  E@"I:.P^82%P&  "^0P  %0              @ &X7P  ;VQM82TR,#(U
M,#$Q,%]L86(N>&UL4$L! A0#%     @ )8 J6LLDG *Q!   ;BH  !4
M         ( !1V8  &]L;6$M,C R-3 Q,3!?<')E+GAM;%!+!08     !0 %
+ #\!   K:P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d915597d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="olma-20250110.xsd" xlink:type="simple"/>
    <context id="duration_2025-01-10_to_2025-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001750284</identifier>
        </entity>
        <period>
            <startDate>2025-01-10</startDate>
            <endDate>2025-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-255">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-01-10_to_2025-01-10"
      id="Hidden_dei_EntityCentralIndexKey">0001750284</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-266">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-267">2025-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-268">Olema Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-269">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-270">001-39712</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-271">30-0409740</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-272">780 Brannan Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-273">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-274">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-275">94103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-276">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-277">651-3316</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-278">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-279">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-280">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-281">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-282">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-283">OLMA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-284">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-285">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
